JP2015527399A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015527399A5 JP2015527399A5 JP2015531237A JP2015531237A JP2015527399A5 JP 2015527399 A5 JP2015527399 A5 JP 2015527399A5 JP 2015531237 A JP2015531237 A JP 2015531237A JP 2015531237 A JP2015531237 A JP 2015531237A JP 2015527399 A5 JP2015527399 A5 JP 2015527399A5
- Authority
- JP
- Japan
- Prior art keywords
- fluoropyrazolo
- indol
- indole
- dihydropyrazolo
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- -1 thiopheneyl Chemical group 0.000 claims 117
- 150000001875 compounds Chemical class 0.000 claims 19
- 150000003839 salts Chemical class 0.000 claims 18
- 125000005843 halogen group Chemical group 0.000 claims 14
- 125000001424 substituent group Chemical group 0.000 claims 13
- 125000004093 cyano group Chemical group *C#N 0.000 claims 12
- 229910052739 hydrogen Inorganic materials 0.000 claims 10
- 239000001257 hydrogen Substances 0.000 claims 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 9
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 125000004076 pyridyl group Chemical group 0.000 claims 6
- TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 229960002965 pravastatin Drugs 0.000 claims 5
- TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 claims 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 4
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 4
- 125000005955 1H-indazolyl group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000003373 pyrazinyl group Chemical group 0.000 claims 3
- 125000003226 pyrazolyl group Chemical group 0.000 claims 3
- 125000005899 2,3-dihydro-1H-pyrrolo[2,3-b]pyridinyl group Chemical group 0.000 claims 2
- TZDONXAHPXKEGZ-UHFFFAOYSA-N 6-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-1-(2-hydroxyethyl)-5-methyl-3h-imidazo[4,5-b]pyridin-2-one Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CC(N(CCO)C(=O)N2)=C2N=C1C TZDONXAHPXKEGZ-UHFFFAOYSA-N 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims 2
- 208000032928 Dyslipidaemia Diseases 0.000 claims 2
- 208000002705 Glucose Intolerance Diseases 0.000 claims 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims 2
- 206010022489 Insulin Resistance Diseases 0.000 claims 2
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 2
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 claims 2
- 201000010390 abdominal obesity-metabolic syndrome 1 Diseases 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 2
- 125000005873 benzo[d]thiazolyl group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 201000001421 hyperglycemia Diseases 0.000 claims 2
- 125000002883 imidazolyl group Chemical group 0.000 claims 2
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 claims 2
- 125000001041 indolyl group Chemical group 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 claims 2
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims 2
- 125000000842 isoxazolyl group Chemical group 0.000 claims 2
- 208000011661 metabolic syndrome X Diseases 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 claims 2
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 claims 2
- 201000010065 polycystic ovary syndrome Diseases 0.000 claims 2
- 201000009104 prediabetes syndrome Diseases 0.000 claims 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 2
- 125000002098 pyridazinyl group Chemical group 0.000 claims 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 2
- 125000003831 tetrazolyl group Chemical group 0.000 claims 2
- 125000000335 thiazolyl group Chemical group 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- VVQSCGIRSJAVKW-AJLCLMPTSA-N (1r,2r,5s)-3-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]-3-azabicyclo[3.1.0]hexane-2-carboxamide Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CN=C(N2[C@H]([C@@H]3C[C@@H]3C2)C(N)=O)N=C1C VVQSCGIRSJAVKW-AJLCLMPTSA-N 0.000 claims 1
- VVQSCGIRSJAVKW-QAMHXRKUSA-N (1r,2s,5s)-3-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]-3-azabicyclo[3.1.0]hexane-2-carboxamide Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CN=C(N2[C@@H]([C@@H]3C[C@@H]3C2)C(N)=O)N=C1C VVQSCGIRSJAVKW-QAMHXRKUSA-N 0.000 claims 1
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 claims 1
- JVXZMZFHASCFTM-SECBINFHSA-N (2r)-1-[[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]amino]propan-2-ol Chemical compound CC1=NC(NC[C@H](O)C)=NC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 JVXZMZFHASCFTM-SECBINFHSA-N 0.000 claims 1
- RNDRRILNXQNKKZ-SNVBAGLBSA-N (2r)-1-[[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-6-methylpyridin-2-yl]amino]propan-2-ol Chemical compound CC1=NC(NC[C@H](O)C)=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 RNDRRILNXQNKKZ-SNVBAGLBSA-N 0.000 claims 1
- MYNYHVTZJXRKKZ-GFCCVEGCSA-N (2r)-3-[6-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-5-methylimidazo[4,5-b]pyridin-3-yl]propane-1,2-diol Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CC(N=CN2C[C@@H](O)CO)=C2N=C1C MYNYHVTZJXRKKZ-GFCCVEGCSA-N 0.000 claims 1
- LKJUSTPUAXMOMO-LLVKDONJSA-N (2r)-3-[[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]amino]propane-1,2-diol Chemical compound CC1=NC(NC[C@@H](O)CO)=NC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 LKJUSTPUAXMOMO-LLVKDONJSA-N 0.000 claims 1
- JVXZMZFHASCFTM-VIFPVBQESA-N (2s)-1-[[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]amino]propan-2-ol Chemical compound CC1=NC(NC[C@@H](O)C)=NC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 JVXZMZFHASCFTM-VIFPVBQESA-N 0.000 claims 1
- XFLZIIASAHFMPT-VIFPVBQESA-N (2s)-2-[[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]amino]propan-1-ol Chemical compound CC1=NC(N[C@H](CO)C)=NC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 XFLZIIASAHFMPT-VIFPVBQESA-N 0.000 claims 1
- MYNYHVTZJXRKKZ-LBPRGKRZSA-N (2s)-3-[6-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-5-methylimidazo[4,5-b]pyridin-3-yl]propane-1,2-diol Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CC(N=CN2C[C@H](O)CO)=C2N=C1C MYNYHVTZJXRKKZ-LBPRGKRZSA-N 0.000 claims 1
- GFMMMVIGRGRSEL-UHFFFAOYSA-N (3-aminoazetidin-1-yl)-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyridin-2-yl]methanone Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=CC=1C(=O)N1CC(N)C1 GFMMMVIGRGRSEL-UHFFFAOYSA-N 0.000 claims 1
- CTBMTGKGHSVVLR-UHFFFAOYSA-N (3-aminoazetidin-1-yl)-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-6-methylpyridin-2-yl]methanone Chemical compound C=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1C(=O)N1CC(N)C1 CTBMTGKGHSVVLR-UHFFFAOYSA-N 0.000 claims 1
- ZGGHKIMDNBDHJB-NRFPMOEYSA-M (3R,5S)-fluvastatin sodium Chemical compound [Na+].C12=CC=CC=C2N(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 ZGGHKIMDNBDHJB-NRFPMOEYSA-M 0.000 claims 1
- ZRTDJGCQJYSPSV-CYBMUJFWSA-N (3r)-1-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]piperidin-3-ol Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1CCC[C@@H](O)C1 ZRTDJGCQJYSPSV-CYBMUJFWSA-N 0.000 claims 1
- KKFJVSMJOYXFQJ-GFCCVEGCSA-N (3r)-1-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]pyrrolidin-3-ol Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1CC[C@@H](O)C1 KKFJVSMJOYXFQJ-GFCCVEGCSA-N 0.000 claims 1
- BVWYKVYJKDAOHM-CYBMUJFWSA-N (3r)-1-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-6-methylpyridin-2-yl]pyrrolidin-3-ol Chemical compound C=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1CC[C@@H](O)C1 BVWYKVYJKDAOHM-CYBMUJFWSA-N 0.000 claims 1
- ZPZQUANGRXUVAS-HZPDHXFCSA-N (3r,4r)-1-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]pyrrolidine-3,4-diol Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1C[C@@H](O)[C@H](O)C1 ZPZQUANGRXUVAS-HZPDHXFCSA-N 0.000 claims 1
- ZRTDJGCQJYSPSV-ZDUSSCGKSA-N (3s)-1-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]piperidin-3-ol Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1CCC[C@H](O)C1 ZRTDJGCQJYSPSV-ZDUSSCGKSA-N 0.000 claims 1
- KKFJVSMJOYXFQJ-LBPRGKRZSA-N (3s)-1-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]pyrrolidin-3-ol Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1CC[C@H](O)C1 KKFJVSMJOYXFQJ-LBPRGKRZSA-N 0.000 claims 1
- BVWYKVYJKDAOHM-ZDUSSCGKSA-N (3s)-1-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-6-methylpyridin-2-yl]pyrrolidin-3-ol Chemical compound C=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1CC[C@H](O)C1 BVWYKVYJKDAOHM-ZDUSSCGKSA-N 0.000 claims 1
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 1
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 claims 1
- 125000005960 1,4-diazepanyl group Chemical group 0.000 claims 1
- 125000005940 1,4-dioxanyl group Chemical group 0.000 claims 1
- HKDFRDIIELOLTJ-UHFFFAOYSA-N 1,4-dithianyl Chemical group [CH]1CSCCS1 HKDFRDIIELOLTJ-UHFFFAOYSA-N 0.000 claims 1
- BOVGTQGAOIONJV-BETUJISGSA-N 1-[(3ar,6as)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-2-yl]-3-(4-methylphenyl)sulfonylurea Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NN1C[C@H]2CCC[C@H]2C1 BOVGTQGAOIONJV-BETUJISGSA-N 0.000 claims 1
- JAIZHQLBZUGIQV-UHFFFAOYSA-N 1-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]azetidin-3-ol Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1CC(O)C1 JAIZHQLBZUGIQV-UHFFFAOYSA-N 0.000 claims 1
- CDKNKEYEZIFKOB-UHFFFAOYSA-N 1-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]piperidine-4-carbonitrile Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1CCC(C#N)CC1 CDKNKEYEZIFKOB-UHFFFAOYSA-N 0.000 claims 1
- KKYCXXHACYYMAT-UHFFFAOYSA-N 1-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-6-methylpyridine-2-carbonyl]azetidine-3-carbonitrile Chemical compound C=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1C(=O)N1CC(C#N)C1 KKYCXXHACYYMAT-UHFFFAOYSA-N 0.000 claims 1
- VTAKZNRDSPNOAU-UHFFFAOYSA-M 2-(chloromethyl)oxirane;hydron;prop-2-en-1-amine;n-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;dichloride Chemical compound Cl.[Cl-].NCC=C.ClCC1CO1.CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C VTAKZNRDSPNOAU-UHFFFAOYSA-M 0.000 claims 1
- RJMOCFHZZVNPMG-UHFFFAOYSA-N 2-[6-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-5-methylimidazo[4,5-b]pyridin-3-yl]ethanol Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CC(N=CN2CCO)=C2N=C1C RJMOCFHZZVNPMG-UHFFFAOYSA-N 0.000 claims 1
- JUQPWBIRVPOLPW-UHFFFAOYSA-N 2-[[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyridin-2-yl]-methylamino]ethanol Chemical compound C1=NC(N(CCO)C)=CC(C)=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 JUQPWBIRVPOLPW-UHFFFAOYSA-N 0.000 claims 1
- HRQSQNPDQBTKRC-UHFFFAOYSA-N 2-[[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]amino]ethanol Chemical compound CC1=NC(NCCO)=NC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 HRQSQNPDQBTKRC-UHFFFAOYSA-N 0.000 claims 1
- 125000001698 2H-pyranyl group Chemical group O1C(C=CC=C1)* 0.000 claims 1
- NTFZDFZVGNCXQP-UHFFFAOYSA-N 3-[6-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-5-methylimidazo[4,5-b]pyridin-3-yl]propan-1-ol Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CC(N=CN2CCCO)=C2N=C1C NTFZDFZVGNCXQP-UHFFFAOYSA-N 0.000 claims 1
- BXLCENGNDVFRAZ-UHFFFAOYSA-N 3-hydroxyazetidine-1-carbaldehyde Chemical compound OC1CN(C=O)C1 BXLCENGNDVFRAZ-UHFFFAOYSA-N 0.000 claims 1
- FPGGLMIYNLQOID-UHFFFAOYSA-N 3h-pyridin-2-one Chemical compound O=C1CC=CC=N1 FPGGLMIYNLQOID-UHFFFAOYSA-N 0.000 claims 1
- PSXVTQZWNCZZEK-UHFFFAOYSA-N 4-(1,4-dimethylindazol-5-yl)-7-fluoro-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=C(C)C(C=NN2C)=C2C=C1 PSXVTQZWNCZZEK-UHFFFAOYSA-N 0.000 claims 1
- OGFYDTCSKYEYQW-UHFFFAOYSA-N 4-(1,5-dimethylindazol-6-yl)-7-fluoro-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CC(N(C)N=C2)=C2C=C1C OGFYDTCSKYEYQW-UHFFFAOYSA-N 0.000 claims 1
- FSDBXNSGEOIMLV-UHFFFAOYSA-N 4-(1-ethyl-3,5-dimethylpyrazol-4-yl)-7-fluoro-1h-pyrazolo[4,3-b]indole Chemical compound CCN1N=C(C)C(N2C3=CC=C(F)C=C3C=3NN=CC=32)=C1C FSDBXNSGEOIMLV-UHFFFAOYSA-N 0.000 claims 1
- KUOHQQCPDGBENS-UHFFFAOYSA-N 4-(2,5-dimethylindazol-6-yl)-7-fluoro-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CC2=NN(C)C=C2C=C1C KUOHQQCPDGBENS-UHFFFAOYSA-N 0.000 claims 1
- MVLJEXMTANOCNN-UHFFFAOYSA-N 4-(2,6-dimethylindazol-5-yl)-7-fluoro-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CC2=CN(C)N=C2C=C1C MVLJEXMTANOCNN-UHFFFAOYSA-N 0.000 claims 1
- SLJDDLKTPNNCBT-UHFFFAOYSA-N 4-(2,6-dimethylpyridin-3-yl)-7-fluoro-1h-pyrazolo[4,3-b]indole Chemical compound CC1=NC(C)=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 SLJDDLKTPNNCBT-UHFFFAOYSA-N 0.000 claims 1
- IUZBXISRROMZSL-UHFFFAOYSA-N 4-(3,5-dimethylimidazo[4,5-b]pyridin-6-yl)-7-fluoro-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CC(N=CN2C)=C2N=C1C IUZBXISRROMZSL-UHFFFAOYSA-N 0.000 claims 1
- MKXDGJICFKWFKG-UHFFFAOYSA-N 4-(3-ethyl-5-methylimidazo[4,5-b]pyridin-6-yl)-7-fluoro-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=C(C)N=C2N(CC)C=NC2=C1 MKXDGJICFKWFKG-UHFFFAOYSA-N 0.000 claims 1
- OWDFYKWZCMOMNL-UHFFFAOYSA-N 4-(5-ethyl-6,7-dihydro-4h-pyrazolo[1,5-a]pyrazin-3-yl)-7-fluoro-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C(C=N1)=C2N1CCN(CC)C2 OWDFYKWZCMOMNL-UHFFFAOYSA-N 0.000 claims 1
- LYDNIWUUAXKIEE-UHFFFAOYSA-N 4-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-1h-pyrazole-5-carbonitrile Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C=1C=NNC=1C#N LYDNIWUUAXKIEE-UHFFFAOYSA-N 0.000 claims 1
- OTERKSQZXOAQLU-UHFFFAOYSA-N 4-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n-(2-hydroxyethyl)-3-methylbenzamide Chemical compound CC1=CC(C(=O)NCCO)=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 OTERKSQZXOAQLU-UHFFFAOYSA-N 0.000 claims 1
- RKBBSKVVMWTWSP-UHFFFAOYSA-N 4-[2-(3,3-difluoroazetidin-1-yl)-4-methylpyrimidin-5-yl]-7-fluoro-1h-pyrazolo[4,3-b]indole Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1CC(F)(F)C1 RKBBSKVVMWTWSP-UHFFFAOYSA-N 0.000 claims 1
- MOXHTKRNDVXYQH-UHFFFAOYSA-N 4-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]-1-methylpiperazin-2-one Chemical compound C1C(=O)N(C)CCN1C1=NC=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=N1 MOXHTKRNDVXYQH-UHFFFAOYSA-N 0.000 claims 1
- SUCKSZMUUYQFPE-UHFFFAOYSA-N 4-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]piperazin-2-one Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1CCNC(=O)C1 SUCKSZMUUYQFPE-UHFFFAOYSA-N 0.000 claims 1
- RIKBSXGPFCVVMD-UHFFFAOYSA-N 4-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-6-methylpyridin-2-yl]morpholine Chemical compound C=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1CCOCC1 RIKBSXGPFCVVMD-UHFFFAOYSA-N 0.000 claims 1
- YRZJHIFXPFONPA-UHFFFAOYSA-N 4-benzyl-6,7-difluoro-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C=2C=C(F)C(F)=CC=2N1CC1=CC=CC=C1 YRZJHIFXPFONPA-UHFFFAOYSA-N 0.000 claims 1
- BHJMIMMYHSMRMK-UHFFFAOYSA-N 4-benzyl-7-fluoro-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1CC1=CC=CC=C1 BHJMIMMYHSMRMK-UHFFFAOYSA-N 0.000 claims 1
- BZDZEPPVFCZALI-UHFFFAOYSA-N 5-(7-fluoro-1H-pyrazolo[4,3-b]indol-4-yl)-N-(2-methoxyethyl)-4-methylpyridine-2-carboxamide Chemical compound FC1=CC=2C3=C(N(C2C=C1)C=1C(=CC(=NC1)C(=O)NCCOC)C)C=NN3 BZDZEPPVFCZALI-UHFFFAOYSA-N 0.000 claims 1
- UDYJXQLMLNNFKF-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-1-methylpyrazole-3-carboxamide Chemical compound CN1N=C(C(N)=O)C=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 UDYJXQLMLNNFKF-UHFFFAOYSA-N 0.000 claims 1
- KUNLGEIDYTZFHY-SNVBAGLBSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-2-[(3r)-3-hydroxypyrrolidin-1-yl]-1h-pyrimidin-6-one Chemical compound C1[C@H](O)CCN1C(NC1=O)=NC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 KUNLGEIDYTZFHY-SNVBAGLBSA-N 0.000 claims 1
- PMOUPCPHWZIIDJ-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-3,4-dimethylpyridin-2-amine Chemical compound CC1=C(N)N=CC(N2C3=CC=C(F)C=C3C=3NN=CC=32)=C1C PMOUPCPHWZIIDJ-UHFFFAOYSA-N 0.000 claims 1
- XILNQDGEMCTTDH-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyridin-2-amine Chemical compound CC1=CC(N)=NC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 XILNQDGEMCTTDH-UHFFFAOYSA-N 0.000 claims 1
- QRUUCMHHMXMVTP-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyridine-2-carboxamide Chemical compound CC1=CC(C(N)=O)=NC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 QRUUCMHHMXMVTP-UHFFFAOYSA-N 0.000 claims 1
- AQJZFCBAFGBITJ-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-amine Chemical compound CC1=NC(N)=NC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 AQJZFCBAFGBITJ-UHFFFAOYSA-N 0.000 claims 1
- GLRNWVJKGLNZFV-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-6-methyl-1h-pyridin-2-one Chemical compound N1C(=O)C=CC(N2C3=CC=C(F)C=C3C=3NN=CC=32)=C1C GLRNWVJKGLNZFV-UHFFFAOYSA-N 0.000 claims 1
- DTVNCJQGACMIIV-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-6-methylpyridin-2-amine Chemical compound CC1=NC(N)=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 DTVNCJQGACMIIV-UHFFFAOYSA-N 0.000 claims 1
- ZYDAFXAZKNYBDP-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n,4-dimethylpyridin-2-amine Chemical compound C1=NC(NC)=CC(C)=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 ZYDAFXAZKNYBDP-UHFFFAOYSA-N 0.000 claims 1
- ANAQPLOTTOOVNV-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n,4-dimethylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)NC)=CC(C)=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 ANAQPLOTTOOVNV-UHFFFAOYSA-N 0.000 claims 1
- UCQDYXZRRRKHKE-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n,6-dimethylpyridine-2-carboxamide Chemical compound CC1=NC(C(=O)NC)=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 UCQDYXZRRRKHKE-UHFFFAOYSA-N 0.000 claims 1
- SRMRNJQSSJRSJJ-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n,n,4-trimethylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)N(C)C)=CC(C)=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 SRMRNJQSSJRSJJ-UHFFFAOYSA-N 0.000 claims 1
- NWAFZOQKWYFAND-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n-(2-hydroxyethyl)-1-methylpyrazole-3-carboxamide Chemical compound CN1N=C(C(=O)NCCO)C=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 NWAFZOQKWYFAND-UHFFFAOYSA-N 0.000 claims 1
- WQRAFCYWQVQSLM-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n-(2-hydroxyethyl)-4-methylpyridine-2-carboxamide Chemical compound CC1=CC(C(=O)NCCO)=NC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 WQRAFCYWQVQSLM-UHFFFAOYSA-N 0.000 claims 1
- DFAQLUXZASRGNV-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n-(2-hydroxyethyl)-6-methylpyridine-2-carboxamide Chemical compound CC1=NC(C(=O)NCCO)=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 DFAQLUXZASRGNV-UHFFFAOYSA-N 0.000 claims 1
- QTWVXUXAXIDIQJ-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n-(2-hydroxyethyl)-n,6-dimethylpyridine-2-carboxamide Chemical compound CC1=NC(C(=O)N(CCO)C)=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 QTWVXUXAXIDIQJ-UHFFFAOYSA-N 0.000 claims 1
- DYTNRLKNPPUCBN-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n-(2-methoxyethyl)-6-methylpyridine-2-carboxamide Chemical compound CC1=NC(C(=O)NCCOC)=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 DYTNRLKNPPUCBN-UHFFFAOYSA-N 0.000 claims 1
- KYMSFGAJAKNKQD-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n-(3-hydroxypropyl)-4-methylpyridine-2-carboxamide Chemical compound CC1=CC(C(=O)NCCCO)=NC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 KYMSFGAJAKNKQD-UHFFFAOYSA-N 0.000 claims 1
- ZAZZGEDRNDDMIR-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n-(3-hydroxypropyl)-6-methylpyridine-2-carboxamide Chemical compound CC1=NC(C(=O)NCCCO)=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 ZAZZGEDRNDDMIR-UHFFFAOYSA-N 0.000 claims 1
- BWLPPOWVJQVABE-SNVBAGLBSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n-[(2r)-2-hydroxypropyl]-6-methylpyridine-2-carboxamide Chemical compound CC1=NC(C(=O)NC[C@H](O)C)=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 BWLPPOWVJQVABE-SNVBAGLBSA-N 0.000 claims 1
- BWLPPOWVJQVABE-JTQLQIEISA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n-[(2s)-2-hydroxypropyl]-6-methylpyridine-2-carboxamide Chemical compound CC1=NC(C(=O)NC[C@@H](O)C)=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 BWLPPOWVJQVABE-JTQLQIEISA-N 0.000 claims 1
- SDYJEGXRICWVMB-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n-[1-(hydroxymethyl)cyclopropyl]-4-methylpyridine-2-carboxamide Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=CC=1C(=O)NC1(CO)CC1 SDYJEGXRICWVMB-UHFFFAOYSA-N 0.000 claims 1
- MBTTVIVBRSZLPG-UHFFFAOYSA-N 5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n-[1-(hydroxymethyl)cyclopropyl]-6-methylpyridine-2-carboxamide Chemical compound C=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1C(=O)NC1(CO)CC1 MBTTVIVBRSZLPG-UHFFFAOYSA-N 0.000 claims 1
- LWQQOBXTPSOJDL-UHFFFAOYSA-N 6,7-difluoro-4-(5-methyl-1h-imidazo[4,5-b]pyridin-6-yl)-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=C(F)C=C2N1C1=CC(NC=N2)=C2N=C1C LWQQOBXTPSOJDL-UHFFFAOYSA-N 0.000 claims 1
- PEWYGTLRHLRPDV-UHFFFAOYSA-N 6,7-difluoro-4-pyridin-3-yl-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C=2C=C(F)C(F)=CC=2N1C1=CC=CN=C1 PEWYGTLRHLRPDV-UHFFFAOYSA-N 0.000 claims 1
- ZGXYSNNZLZWSDJ-UHFFFAOYSA-N 6-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-3-(3-hydroxypropyl)-5-methyl-1h-imidazo[4,5-b]pyridin-2-one Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CC(NC(=O)N2CCCO)=C2N=C1C ZGXYSNNZLZWSDJ-UHFFFAOYSA-N 0.000 claims 1
- AMUJWJIEEPBMJN-UHFFFAOYSA-N 6-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-5-methyl-1,3-dihydroimidazo[4,5-b]pyridin-2-one Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CC(NC(=O)N2)=C2N=C1C AMUJWJIEEPBMJN-UHFFFAOYSA-N 0.000 claims 1
- MLTRKWNLWDDKEU-UHFFFAOYSA-N 6-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-7-methyl-1,3-dihydroimidazo[4,5-b]pyridin-2-one Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=C(C)C(NC(=O)N2)=C2N=C1 MLTRKWNLWDDKEU-UHFFFAOYSA-N 0.000 claims 1
- IPEFGMPMIDTJEW-UHFFFAOYSA-N 6-amino-5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)pyridine-3-carboxylic acid Chemical compound NC1=NC=C(C(O)=O)C=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 IPEFGMPMIDTJEW-UHFFFAOYSA-N 0.000 claims 1
- ZXAPVSLYIINGLH-UHFFFAOYSA-N 6-chloro-4-(5-methyl-1h-imidazo[4,5-b]pyridin-6-yl)-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC=C(Cl)C=C2N1C1=CC(NC=N2)=C2N=C1C ZXAPVSLYIINGLH-UHFFFAOYSA-N 0.000 claims 1
- BIIWWXKROBCNQB-UHFFFAOYSA-N 6-chloro-7-fluoro-4-(5-methyl-1h-imidazo[4,5-b]pyridin-6-yl)-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=C(Cl)C=C2N1C1=CC(NC=N2)=C2N=C1C BIIWWXKROBCNQB-UHFFFAOYSA-N 0.000 claims 1
- PKHRLYLVTPAMDQ-UHFFFAOYSA-N 7-fluoro-4-(1,3,5-trimethylpyrazol-4-yl)-1h-pyrazolo[4,3-b]indole Chemical compound CC1=NN(C)C(C)=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 PKHRLYLVTPAMDQ-UHFFFAOYSA-N 0.000 claims 1
- XMQKDYKZIPIZBO-UHFFFAOYSA-N 7-fluoro-4-(1-phenylethyl)-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C(C)C1=CC=CC=C1 XMQKDYKZIPIZBO-UHFFFAOYSA-N 0.000 claims 1
- WQSXXYVWURXQHK-UHFFFAOYSA-N 7-fluoro-4-(2-methyl-6-piperazin-1-ylpyridin-3-yl)-1h-pyrazolo[4,3-b]indole Chemical compound C=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1CCNCC1 WQSXXYVWURXQHK-UHFFFAOYSA-N 0.000 claims 1
- CQPVFNFMSYBFNM-UHFFFAOYSA-N 7-fluoro-4-(2-methylpyrazol-3-yl)-1h-pyrazolo[4,3-b]indole Chemical compound CN1N=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 CQPVFNFMSYBFNM-UHFFFAOYSA-N 0.000 claims 1
- ANPBEMFSBAZYTH-UHFFFAOYSA-N 7-fluoro-4-(2-methylpyridin-3-yl)-1h-pyrazolo[4,3-b]indole Chemical compound CC1=NC=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 ANPBEMFSBAZYTH-UHFFFAOYSA-N 0.000 claims 1
- YRZSLWOEBGOYCT-UHFFFAOYSA-N 7-fluoro-4-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl)-1h-pyrazolo[4,3-b]indole Chemical compound C1=NN2CCNCC2=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 YRZSLWOEBGOYCT-UHFFFAOYSA-N 0.000 claims 1
- GKLASFPXAFLKOS-UHFFFAOYSA-N 7-fluoro-4-(4-methyl-1h-indazol-5-yl)-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=C(C)C(C=NN2)=C2C=C1 GKLASFPXAFLKOS-UHFFFAOYSA-N 0.000 claims 1
- BGZYUWQQATZBHE-UHFFFAOYSA-N 7-fluoro-4-(4-methylpyrimidin-5-yl)-1h-pyrazolo[4,3-b]indole Chemical compound CC1=NC=NC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 BGZYUWQQATZBHE-UHFFFAOYSA-N 0.000 claims 1
- BGVWCIRYUNODHW-UHFFFAOYSA-N 7-fluoro-4-(5-methyl-1h-imidazo[4,5-b]pyridin-6-yl)-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CC(NC=N2)=C2N=C1C BGVWCIRYUNODHW-UHFFFAOYSA-N 0.000 claims 1
- BAHHORPTLRLLTM-UHFFFAOYSA-N 7-fluoro-4-(5-methyl-1h-indazol-6-yl)-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CC(NN=C2)=C2C=C1C BAHHORPTLRLLTM-UHFFFAOYSA-N 0.000 claims 1
- RNWCXVSCZJOBKL-UHFFFAOYSA-N 7-fluoro-4-(5-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=C(C)N2N=CN=C2C=C1 RNWCXVSCZJOBKL-UHFFFAOYSA-N 0.000 claims 1
- GPAMAFNHQLQOTA-UHFFFAOYSA-N 7-fluoro-4-(6-methoxy-2-methylpyridin-3-yl)-1h-pyrazolo[4,3-b]indole Chemical compound CC1=NC(OC)=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 GPAMAFNHQLQOTA-UHFFFAOYSA-N 0.000 claims 1
- XXKLVEQACZAVIB-UHFFFAOYSA-N 7-fluoro-4-(6-methyl-1h-indazol-5-yl)-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CC(C=NN2)=C2C=C1C XXKLVEQACZAVIB-UHFFFAOYSA-N 0.000 claims 1
- IYGXIFDOCWWMLQ-UHFFFAOYSA-N 7-fluoro-4-(6-methylpyridin-2-yl)-1h-pyrazolo[4,3-b]indole Chemical compound CC1=CC=CC(N2C3=CC=C(F)C=C3C=3NN=CC=32)=N1 IYGXIFDOCWWMLQ-UHFFFAOYSA-N 0.000 claims 1
- RRCNPYRCOUOTDZ-UHFFFAOYSA-N 7-fluoro-4-(7-methyl-1h-imidazo[4,5-b]pyridin-6-yl)-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=C(C)C(NC=N2)=C2N=C1 RRCNPYRCOUOTDZ-UHFFFAOYSA-N 0.000 claims 1
- GZVOXNRYSRNICD-UHFFFAOYSA-N 7-fluoro-4-[2-(4-methylpiperazin-1-yl)pyridin-4-yl]-1h-pyrazolo[4,3-b]indole Chemical compound C1CN(C)CCN1C1=CC(N2C3=CC=C(F)C=C3C=3NN=CC=32)=CC=N1 GZVOXNRYSRNICD-UHFFFAOYSA-N 0.000 claims 1
- GJZBZIZRWWCQCP-GFCCVEGCSA-N 7-fluoro-4-[2-[(3r)-3-fluoropyrrolidin-1-yl]-4-methylpyrimidin-5-yl]-1h-pyrazolo[4,3-b]indole Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1CC[C@@H](F)C1 GJZBZIZRWWCQCP-GFCCVEGCSA-N 0.000 claims 1
- GJZBZIZRWWCQCP-LBPRGKRZSA-N 7-fluoro-4-[2-[(3s)-3-fluoropyrrolidin-1-yl]-4-methylpyrimidin-5-yl]-1h-pyrazolo[4,3-b]indole Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1CC[C@H](F)C1 GJZBZIZRWWCQCP-LBPRGKRZSA-N 0.000 claims 1
- UCYIXXMYPVYCPX-UHFFFAOYSA-N 7-fluoro-4-[2-methyl-6-(2-methylsulfonylethyl)pyridin-3-yl]-1h-pyrazolo[4,3-b]indole Chemical compound CC1=NC(CCS(C)(=O)=O)=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 UCYIXXMYPVYCPX-UHFFFAOYSA-N 0.000 claims 1
- SVUSGXJDDQWLGX-UHFFFAOYSA-N 7-fluoro-4-[2-methyl-6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1h-pyrazolo[4,3-b]indole Chemical compound C1CN(C)CCN1C1=CC=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=N1 SVUSGXJDDQWLGX-UHFFFAOYSA-N 0.000 claims 1
- KCFQVFSOPOVIBQ-UHFFFAOYSA-N 7-fluoro-4-[3-(2-methoxyethyl)-5-methylimidazo[4,5-b]pyridin-6-yl]-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=C(C)N=C2N(CCOC)C=NC2=C1 KCFQVFSOPOVIBQ-UHFFFAOYSA-N 0.000 claims 1
- WPAIXVACTNYNIE-ZDUSSCGKSA-N 7-fluoro-4-[4-methyl-2-[(3s)-3-methylsulfonylpyrrolidin-1-yl]pyrimidin-5-yl]-1h-pyrazolo[4,3-b]indole Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1CC[C@H](S(C)(=O)=O)C1 WPAIXVACTNYNIE-ZDUSSCGKSA-N 0.000 claims 1
- XFIANOKXLWYJBW-UHFFFAOYSA-N 7-fluoro-4-[5-(methoxymethyl)-1h-pyrazol-4-yl]-1h-pyrazolo[4,3-b]indole Chemical compound N1N=CC(N2C3=CC=C(F)C=C3C=3NN=CC=32)=C1COC XFIANOKXLWYJBW-UHFFFAOYSA-N 0.000 claims 1
- BPCCTTNRJCTGHS-UHFFFAOYSA-N 7-fluoro-4-pyridin-3-yl-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C1=CC=CN=C1 BPCCTTNRJCTGHS-UHFFFAOYSA-N 0.000 claims 1
- PAHCDROMZXOPDL-UHFFFAOYSA-N 7-fluoro-6-methyl-4-(5-methyl-1h-imidazo[4,5-b]pyridin-6-yl)-1h-pyrazolo[4,3-b]indole Chemical compound C1=2C=NNC=2C=2C=C(F)C(C)=CC=2N1C(C(=N1)C)=CC2=C1N=CN2 PAHCDROMZXOPDL-UHFFFAOYSA-N 0.000 claims 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 claims 1
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 claims 1
- RKWGIWYCVPQPMF-UHFFFAOYSA-N Chloropropamide Chemical compound CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1 RKWGIWYCVPQPMF-UHFFFAOYSA-N 0.000 claims 1
- 229920001268 Cholestyramine Polymers 0.000 claims 1
- 229920002905 Colesevelam Polymers 0.000 claims 1
- 229920002911 Colestipol Polymers 0.000 claims 1
- HTQBXNHDCUEHJF-XWLPCZSASA-N Exenatide Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 HTQBXNHDCUEHJF-XWLPCZSASA-N 0.000 claims 1
- 108010011459 Exenatide Proteins 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- FAEKWTJYAYMJKF-QHCPKHFHSA-N GlucoNorm Chemical compound C1=C(C(O)=O)C(OCC)=CC(CC(=O)N[C@@H](CC(C)C)C=2C(=CC=CC=2)N2CCCCC2)=C1 FAEKWTJYAYMJKF-QHCPKHFHSA-N 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- LTXREWYXXSTFRX-QGZVFWFLSA-N Linagliptin Chemical compound N=1C=2N(C)C(=O)N(CC=3N=C4C=CC=CC4=C(C)N=3)C(=O)C=2N(CC#CC)C=1N1CCC[C@@H](N)C1 LTXREWYXXSTFRX-QGZVFWFLSA-N 0.000 claims 1
- YSDQQAXHVYUZIW-QCIJIYAXSA-N Liraglutide Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCC)C(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 YSDQQAXHVYUZIW-QCIJIYAXSA-N 0.000 claims 1
- 108010019598 Liraglutide Proteins 0.000 claims 1
- IBAQFPQHRJAVAV-ULAWRXDQSA-N Miglitol Chemical compound OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO IBAQFPQHRJAVAV-ULAWRXDQSA-N 0.000 claims 1
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 claims 1
- 206010033307 Overweight Diseases 0.000 claims 1
- AJLFOPYRIVGYMJ-UHFFFAOYSA-N SJ000287055 Natural products C12C(OC(=O)C(C)CC)CCC=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 AJLFOPYRIVGYMJ-UHFFFAOYSA-N 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- JLRGJRBPOGGCBT-UHFFFAOYSA-N Tolbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 JLRGJRBPOGGCBT-UHFFFAOYSA-N 0.000 claims 1
- DTDWYWOXVWNHBF-UHFFFAOYSA-N [1-(difluoromethyl)-4-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)pyrazol-3-yl]methanol Chemical compound OCC1=NN(C(F)F)C=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 DTDWYWOXVWNHBF-UHFFFAOYSA-N 0.000 claims 1
- CBZXPJLHIWZSJJ-UHFFFAOYSA-N [1-[5-(7-fluoro-1H-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]azetidin-3-yl]methanol Chemical compound FC1=CC=2C3=C(N(C2C=C1)C=1C(=NC(=NC1)N1CC(C1)CO)C)C=NN3 CBZXPJLHIWZSJJ-UHFFFAOYSA-N 0.000 claims 1
- JXTQHICBEHRVPQ-UHFFFAOYSA-N [1-[5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyrimidin-2-yl]piperidin-4-yl]methanol Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1N1CCC(CO)CC1 JXTQHICBEHRVPQ-UHFFFAOYSA-N 0.000 claims 1
- FKROPYPGXGWRCM-UHFFFAOYSA-N [4-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-1-methylpyrazol-3-yl]methanol Chemical compound OCC1=NN(C)C=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 FKROPYPGXGWRCM-UHFFFAOYSA-N 0.000 claims 1
- HIZWMLPCMQJIKI-UHFFFAOYSA-N [4-[(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)methyl]phenyl]-(4-methylpiperazin-1-yl)methanone Chemical compound C1CN(C)CCN1C(=O)C(C=C1)=CC=C1CN1C2=CC=C(F)C=C2C2=C1C=NN2 HIZWMLPCMQJIKI-UHFFFAOYSA-N 0.000 claims 1
- VMOTYFACJUDBEV-UHFFFAOYSA-N [4-[(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)methyl]phenyl]-morpholin-4-ylmethanone Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1CC(C=C1)=CC=C1C(=O)N1CCOCC1 VMOTYFACJUDBEV-UHFFFAOYSA-N 0.000 claims 1
- RSFQSOXGJGEZBD-UHFFFAOYSA-N [5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyridin-2-yl]-(3-hydroxyazetidin-1-yl)methanone Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=CC=1C(=O)N1CC(O)C1 RSFQSOXGJGEZBD-UHFFFAOYSA-N 0.000 claims 1
- NRCFQLGHARGZHK-CYBMUJFWSA-N [5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyridin-2-yl]-[(3r)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=CC=1C(=O)N1CC[C@@H](O)C1 NRCFQLGHARGZHK-CYBMUJFWSA-N 0.000 claims 1
- ZIDQZVHFJOGZFR-UHFFFAOYSA-N [5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-4-methylpyridin-2-yl]-morpholin-4-ylmethanone Chemical compound N=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=CC=1C(=O)N1CCOCC1 ZIDQZVHFJOGZFR-UHFFFAOYSA-N 0.000 claims 1
- RGZZJAMJGFBKLH-UHFFFAOYSA-N [5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-6-methylpyridin-2-yl]-(3-hydroxyazetidin-1-yl)methanone Chemical compound C=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1C(=O)N1CC(O)C1 RGZZJAMJGFBKLH-UHFFFAOYSA-N 0.000 claims 1
- 229960002632 acarbose Drugs 0.000 claims 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 claims 1
- 229960001466 acetohexamide Drugs 0.000 claims 1
- VGZSUPCWNCWDAN-UHFFFAOYSA-N acetohexamide Chemical compound C1=CC(C(=O)C)=CC=C1S(=O)(=O)NC(=O)NC1CCCCC1 VGZSUPCWNCWDAN-UHFFFAOYSA-N 0.000 claims 1
- 229960001667 alogliptin Drugs 0.000 claims 1
- ZSBOMTDTBDDKMP-OAHLLOKOSA-N alogliptin Chemical compound C=1C=CC=C(C#N)C=1CN1C(=O)N(C)C(=O)C=C1N1CCC[C@@H](N)C1 ZSBOMTDTBDDKMP-OAHLLOKOSA-N 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 229960005370 atorvastatin Drugs 0.000 claims 1
- 125000003725 azepanyl group Chemical group 0.000 claims 1
- 125000002393 azetidinyl group Chemical group 0.000 claims 1
- 125000004069 aziridinyl group Chemical group 0.000 claims 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 claims 1
- 229960004111 buformin Drugs 0.000 claims 1
- XSEUMFJMFFMCIU-UHFFFAOYSA-N buformin Chemical compound CCCC\N=C(/N)N=C(N)N XSEUMFJMFFMCIU-UHFFFAOYSA-N 0.000 claims 1
- 229960001761 chlorpropamide Drugs 0.000 claims 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 claims 1
- 229960001214 clofibrate Drugs 0.000 claims 1
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 claims 1
- 229960001152 colesevelam Drugs 0.000 claims 1
- GMRWGQCZJGVHKL-UHFFFAOYSA-N colestipol Chemical compound ClCC1CO1.NCCNCCNCCNCCN GMRWGQCZJGVHKL-UHFFFAOYSA-N 0.000 claims 1
- 229960002604 colestipol Drugs 0.000 claims 1
- PBTZDKJBDRBWTN-UHFFFAOYSA-N cyclopropyl-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)methanone Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C(=O)C1CC1 PBTZDKJBDRBWTN-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229960001519 exenatide Drugs 0.000 claims 1
- OLNTVTPDXPETLC-XPWALMASSA-N ezetimibe Chemical compound N1([C@@H]([C@H](C1=O)CC[C@H](O)C=1C=CC(F)=CC=1)C=1C=CC(O)=CC=1)C1=CC=C(F)C=C1 OLNTVTPDXPETLC-XPWALMASSA-N 0.000 claims 1
- 229960000815 ezetimibe Drugs 0.000 claims 1
- 229960002297 fenofibrate Drugs 0.000 claims 1
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 claims 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 229960003765 fluvastatin Drugs 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 229960004580 glibenclamide Drugs 0.000 claims 1
- 229960000346 gliclazide Drugs 0.000 claims 1
- 229960004346 glimepiride Drugs 0.000 claims 1
- WIGIZIANZCJQQY-RUCARUNLSA-N glimepiride Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C=C1 WIGIZIANZCJQQY-RUCARUNLSA-N 0.000 claims 1
- 229960001381 glipizide Drugs 0.000 claims 1
- ZJJXGWJIGJFDTL-UHFFFAOYSA-N glipizide Chemical compound C1=NC(C)=CN=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZJJXGWJIGJFDTL-UHFFFAOYSA-N 0.000 claims 1
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 claims 1
- 208000000509 infertility Diseases 0.000 claims 1
- 230000036512 infertility Effects 0.000 claims 1
- 231100000535 infertility Toxicity 0.000 claims 1
- 229940125396 insulin Drugs 0.000 claims 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 claims 1
- 125000001786 isothiazolyl group Chemical group 0.000 claims 1
- 229960002397 linagliptin Drugs 0.000 claims 1
- 229960002701 liraglutide Drugs 0.000 claims 1
- 229960004844 lovastatin Drugs 0.000 claims 1
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 claims 1
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 claims 1
- 229960003105 metformin Drugs 0.000 claims 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 claims 1
- 229950009116 mevastatin Drugs 0.000 claims 1
- AJLFOPYRIVGYMJ-INTXDZFKSA-N mevastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=CCC[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 AJLFOPYRIVGYMJ-INTXDZFKSA-N 0.000 claims 1
- BOZILQFLQYBIIY-UHFFFAOYSA-N mevastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CCC=C21 BOZILQFLQYBIIY-UHFFFAOYSA-N 0.000 claims 1
- 229960001110 miglitol Drugs 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- OAJPHLCFGHAQCK-UHFFFAOYSA-N n-(2-amino-2-oxoethyl)-5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-6-methylpyridine-2-carboxamide Chemical compound CC1=NC(C(=O)NCC(N)=O)=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 OAJPHLCFGHAQCK-UHFFFAOYSA-N 0.000 claims 1
- QFBHPDSTXRPXIU-UHFFFAOYSA-N n-(2-cyanoethyl)-5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-6-methylpyridine-2-carboxamide Chemical compound CC1=NC(C(=O)NCCC#N)=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 QFBHPDSTXRPXIU-UHFFFAOYSA-N 0.000 claims 1
- LKWRZFLHHVAZAY-UHFFFAOYSA-N n-(cyanomethyl)-5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-n,6-dimethylpyridine-2-carboxamide Chemical compound CC1=NC(C(=O)N(CC#N)C)=CC=C1N1C2=CC=C(F)C=C2C2=C1C=NN2 LKWRZFLHHVAZAY-UHFFFAOYSA-N 0.000 claims 1
- AEMBWZZXYUVYPH-UHFFFAOYSA-N n-benzyl-7-fluoro-1h-pyrazolo[4,3-b]indole-4-carboxamide Chemical compound C1=2C=NNC=2C2=CC(F)=CC=C2N1C(=O)NCC1=CC=CC=C1 AEMBWZZXYUVYPH-UHFFFAOYSA-N 0.000 claims 1
- PYQYJBHXWRJLPK-UHFFFAOYSA-N n-cyclopropyl-5-(7-fluoro-1h-pyrazolo[4,3-b]indol-4-yl)-6-methylpyridine-2-carboxamide Chemical compound C=1C=C(N2C3=CC=C(F)C=C3C=3NN=CC=32)C(C)=NC=1C(=O)NC1CC1 PYQYJBHXWRJLPK-UHFFFAOYSA-N 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 229960000698 nateglinide Drugs 0.000 claims 1
- OELFLUMRDSZNSF-BRWVUGGUSA-N nateglinide Chemical compound C1C[C@@H](C(C)C)CC[C@@H]1C(=O)N[C@@H](C(O)=O)CC1=CC=CC=C1 OELFLUMRDSZNSF-BRWVUGGUSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 229960001243 orlistat Drugs 0.000 claims 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- 125000003551 oxepanyl group Chemical group 0.000 claims 1
- 125000003566 oxetanyl group Chemical group 0.000 claims 1
- 125000000466 oxiranyl group Chemical group 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 claims 1
- 229960003243 phenformin Drugs 0.000 claims 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 claims 1
- 229960005095 pioglitazone Drugs 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- 229960002797 pitavastatin Drugs 0.000 claims 1
- VGYFMXBACGZSIL-MCBHFWOFSA-N pitavastatin Chemical compound OC(=O)C[C@H](O)C[C@H](O)\C=C\C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1 VGYFMXBACGZSIL-MCBHFWOFSA-N 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 claims 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims 1
- 229960002354 repaglinide Drugs 0.000 claims 1
- 229960004586 rosiglitazone Drugs 0.000 claims 1
- QGJUIPDUBHWZPV-SGTAVMJGSA-N saxagliptin Chemical compound C1C(C2)CC(C3)CC2(O)CC13[C@H](N)C(=O)N1[C@H](C#N)C[C@@H]2C[C@@H]21 QGJUIPDUBHWZPV-SGTAVMJGSA-N 0.000 claims 1
- 229960004937 saxagliptin Drugs 0.000 claims 1
- 108010033693 saxagliptin Proteins 0.000 claims 1
- 229960004034 sitagliptin Drugs 0.000 claims 1
- MFFMDFFZMYYVKS-SECBINFHSA-N sitagliptin Chemical compound C([C@H](CC(=O)N1CC=2N(C(=NN=2)C(F)(F)F)CC1)N)C1=CC(F)=C(F)C=C1F MFFMDFFZMYYVKS-SECBINFHSA-N 0.000 claims 1
- 201000002859 sleep apnea Diseases 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 229950007151 taspoglutide Drugs 0.000 claims 1
- WRGVLTAWMNZWGT-VQSPYGJZSA-N taspoglutide Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 WRGVLTAWMNZWGT-VQSPYGJZSA-N 0.000 claims 1
- 108010048573 taspoglutide Proteins 0.000 claims 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 1
- 125000004632 tetrahydrothiopyranyl group Chemical group S1C(CCCC1)* 0.000 claims 1
- 125000001583 thiepanyl group Chemical group 0.000 claims 1
- 125000002053 thietanyl group Chemical group 0.000 claims 1
- 229960002277 tolazamide Drugs 0.000 claims 1
- OUDSBRTVNLOZBN-UHFFFAOYSA-N tolazamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NN1CCCCCC1 OUDSBRTVNLOZBN-UHFFFAOYSA-N 0.000 claims 1
- 229960005371 tolbutamide Drugs 0.000 claims 1
- 229960001254 vildagliptin Drugs 0.000 claims 1
- SYOKIDBDQMKNDQ-XWTIBIIYSA-N vildagliptin Chemical compound C1C(O)(C2)CC(C3)CC1CC32NCC(=O)N1CCC[C@H]1C#N SYOKIDBDQMKNDQ-XWTIBIIYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261698369P | 2012-09-07 | 2012-09-07 | |
| US61/698,369 | 2012-09-07 | ||
| PCT/US2013/058527 WO2014039831A1 (en) | 2012-09-07 | 2013-09-06 | SUBSTITUTED-1,4-DIHYDROPYRAZOLO[4,3-b]INDOLES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015527399A JP2015527399A (ja) | 2015-09-17 |
| JP2015527399A5 true JP2015527399A5 (enExample) | 2016-11-04 |
Family
ID=49170939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015531237A Abandoned JP2015527399A (ja) | 2012-09-07 | 2013-09-06 | 置換−１，４−ジヒドロピラゾロ［４，３−ｂ］インドール |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9475816B2 (enExample) |
| EP (1) | EP2909212B1 (enExample) |
| JP (1) | JP2015527399A (enExample) |
| WO (1) | WO2014039831A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9309250B2 (en) | 2011-06-22 | 2016-04-12 | Vertex Pharmaceuticals Incorporated | Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors |
| SI2941432T1 (en) | 2012-12-07 | 2018-07-31 | Vertex Pharmaceuticals Incorporated | 2-AMINO-6-FLUORO-N- (5-FLUORO-4- (4- (4- (OXETHAN-3-YL) PIPERAZIN-1-CARBONYL) PIPERIDIN-1-YLIPRIDIN-3-YL) 1,5 ALFA) PYRIMIDINE-3-CARBOXAMIDE AS ATR KINAZE INHIBITOR |
| EP2970288A1 (en) | 2013-03-15 | 2016-01-20 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
| US8957078B2 (en) | 2013-03-15 | 2015-02-17 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| WO2014143240A1 (en) | 2013-03-15 | 2014-09-18 | Vertex Pharmaceuticals Incorporated | Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase |
| PT3077397T (pt) | 2013-12-06 | 2020-01-22 | Vertex Pharma | Composto de 2-amino-6-fluoro-n-[5-fluoro-piridin-3-il]pirazolo[1,5-a]pirimidin-3-carboxamida útil como inibidor da atr quinase, a sua preparação, diferentes formas sólidas e derivados radiomarcados do mesmo |
| MX373102B (es) | 2014-06-05 | 2020-04-17 | Vertex Pharma | Derivados radiomarcados de un compuesto de 2-amino-6-fluoro-n-[5-fluoro-piridin-3-il]-pirazolo[1,5-a]pirimidin-3-carboxamida útil como inhibidor de ataxia telangiectasia mutada y rad3 relacionado (atr) cinasa, preparación de tal compuesto y diferentes formas sólidas del mismo. |
| SG11201610500WA (en) | 2014-06-17 | 2017-01-27 | Vertex Pharma | Method for treating cancer using a combination of chk1 and atr inhibitors |
| US20170042806A1 (en) | 2015-04-29 | 2017-02-16 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
| AU2016331955B2 (en) | 2015-09-30 | 2022-07-21 | Vertex Pharmaceuticals Incorporated | Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| CA3086668A1 (en) * | 2018-02-05 | 2019-08-08 | Universite De Strasbourg | Compounds and compositions for the treatment of pain |
| KR20220044721A (ko) * | 2019-08-06 | 2022-04-11 | 도메인 테라퓨틱스 | 신경펩타이드 ff 수용체 길항제로서의 5-헤테로아릴-피리딘-2-아민 화합물 |
| CN113372281A (zh) * | 2020-03-09 | 2021-09-10 | 河北中科金辉药业有限公司 | 一种特硝唑的合成方法 |
| JP2023524863A (ja) * | 2020-05-08 | 2023-06-13 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 三環式のヘテロ環 |
| WO2021224291A1 (en) * | 2020-05-08 | 2021-11-11 | Merck Patent Gmbh | Tricyclic heterocycles useful as tead binders |
| JP2023552485A (ja) * | 2020-12-14 | 2023-12-15 | キノシス・セラピューティクス・ピーティーワイ・リミテッド | オキシトシン受容体モジュレーター |
| JP7843780B2 (ja) * | 2021-05-05 | 2026-04-10 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 癌の処置に使用するための２，８－ジヒドロピラゾロ［３，４－ｂ］インドール誘導体 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| EP0638071B1 (en) | 1992-12-28 | 1997-04-09 | Eisai Co., Ltd. | Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar) |
| GB9518953D0 (en) | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| WO2000007996A2 (en) | 1998-08-07 | 2000-02-17 | Chiron Corporation | Pyrazoles as estrogen receptor modulators |
| US6462036B1 (en) | 1998-11-06 | 2002-10-08 | Basf Aktiengesellschaft | Tricyclic pyrazole derivatives |
| AU762992B2 (en) | 1998-11-06 | 2003-07-10 | Abbott Gmbh & Co. Kg | Tricyclic pyrazole derivatives |
| US6297238B1 (en) | 1999-04-06 | 2001-10-02 | Basf Aktiengesellschaft | Therapeutic agents |
| US6849644B2 (en) | 2000-11-21 | 2005-02-01 | Smithkline Beecham P.L.C. | Isoquinoline derivatives useful in the treatment of CNS disorders |
| GB0111186D0 (en) | 2001-05-08 | 2001-06-27 | Smithkline Beecham Plc | Novel compounds |
| ES2323952T3 (es) | 2002-05-15 | 2009-07-28 | Janssen Pharmaceutica Nv | 3-aminopirazol triciclicos sustituidos en n como inhibidores receptores de pdfg. |
| WO2004080973A1 (en) * | 2003-03-07 | 2004-09-23 | Abbott Laboratories | Fused tri and tetra-cyclic pyrazole kinase inhibitors |
| EP1740579B1 (en) * | 2004-03-24 | 2015-08-19 | AbbVie Inc. | Tricyclic pyrazole kinase inhibitors |
| US7816536B2 (en) | 2005-06-10 | 2010-10-19 | The Research Foundation Of State University Of New York | 4-substituted and 7-substituted indoles, benzofurans, benzothiophenes, benzimidazoles, benzoxazoles, and benzothiazoles and methods for making same |
| WO2008008650A1 (en) | 2006-07-10 | 2008-01-17 | Indiana University Research And Technology Corporation | Methods for treating cystic kidney diseases |
| CN100586932C (zh) | 2007-01-26 | 2010-02-03 | 中国医学科学院医药生物技术研究所 | 抗肿瘤化合物及其制备方法 |
| US20120004162A1 (en) | 2008-12-04 | 2012-01-05 | Vath James E | Methods of Treating an Overweight or Obese Subject |
| US8642650B2 (en) | 2008-12-04 | 2014-02-04 | Zafgen, Inc. | Methods of treating an overweight or obese subject |
-
2013
- 2013-09-06 US US14/426,369 patent/US9475816B2/en not_active Expired - Fee Related
- 2013-09-06 WO PCT/US2013/058527 patent/WO2014039831A1/en not_active Ceased
- 2013-09-06 JP JP2015531237A patent/JP2015527399A/ja not_active Abandoned
- 2013-09-06 EP EP13762702.2A patent/EP2909212B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015527399A5 (enExample) | ||
| US12331056B2 (en) | SHP2 phosphatase inhibitors and methods of use thereof | |
| US11591336B2 (en) | Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors | |
| US11878976B2 (en) | FGFR3 inhibitor compounds | |
| AU2023356614A1 (en) | Heterocyclic inhibitors of kras g12c mutant proteins and uses thereof | |
| JP5775070B2 (ja) | ヤヌスキナーゼ阻害剤としてのピラゾール−４−イル−ピロロ［２，３−ｄ］ピリミジンおよびピロール−３−イル−ピロロ［２，３−ｄ］ピリミジンのＮ−（ヘテロ）アリール−ピロリジン誘導体 | |
| AU2023356610A1 (en) | Tethered heterocyclic inhibitors of kras g12c mutant proteins and uses thereof | |
| JP2015537010A5 (enExample) | ||
| RU2015122895A (ru) | Пуриновые ингибиторы человеческой фосфатидилинозит 3-киназы дельта | |
| US20240059703A1 (en) | Heterocyclic spiro compounds and methods of use | |
| JP2011526931A (ja) | Ｃｄｋモジュレーター | |
| KR20160092012A (ko) | 피롤로[2,3-d]피리미디닐, 피롤로[2,3-b]피라지닐 및 피롤로[2,3-d]피리디닐 아크릴아미드 | |
| JP2019535689A5 (enExample) | ||
| JP2017501202A5 (enExample) | ||
| JP2017518326A5 (enExample) | ||
| US20240109917A1 (en) | Pyrazolothiazole carboxamides and their uses as pdgfr inhibitors | |
| US20240174674A1 (en) | Nitrogen-containing polycyclic fused ring compound, pharmaceutical composition thereof, preparation method therefor, and use thereof | |
| US20240383875A1 (en) | Benzimidazole Pyridine Derivatives | |
| US20250304577A1 (en) | Tyk2 inhibitors | |
| WO2025017078A1 (en) | New pyrazolopyridine derivatives | |
| US12180226B2 (en) | Spirotricycle RIPK1 inhibitors and methods of uses thereof | |
| WO2023247593A1 (en) | Pyrrolopyridine carboxamides and their uses as pdgfr inhibitors | |
| WO2026055477A1 (en) | Macrocyclic compounds as modulators of kras and uses thereof | |
| WO2023247590A1 (en) | Triazolopyridine and benzoisoxazole carboxamides and their uses as pdgfr inhibitors | |
| WO2025217247A1 (en) | Tethered spiro-heterocyclic inhibitors of kras g12c mutant proteins and uses thereof |